{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T19:54:28Z","timestamp":1782503668635,"version":"3.54.5"},"reference-count":121,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The association between cardiomyopathies (CMPs) and psychiatric disorders is a complex and bidirectional phenomenon that involves multiple mechanisms and factors. CMPs may raise the risk of psychiatric disorders due to the psychological stress, physical limitations, social isolation, or poor prognosis associated with the underlying disease. Psychiatric disorders, on the other hand, can increase the possibility of developing or worsening CMPs due to the behavioral, neuroendocrine, inflammatory, or pharmacological effects of mental illness or its treatment. Moreover, some common genetic or environmental factors may have a relevant influence on both conditions. With this comprehensive review, we sought to provide an overview of the current evidence on the strict and intriguing interconnection between CMPs and psychiatric disorders, focusing on the epidemiology, pathophysiology, clinical implications, and management strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/crd.0000000000000693","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T09:00:26Z","timestamp":1712826026000},"page":"289-299","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Cardiomyopathies and Psychiatric Disorders: An Overview and General Clinical Recommendations"],"prefix":"10.1097","volume":"34","author":[{"given":"Alessandro","family":"Stanca","sequence":"first","affiliation":[{"name":"From the University Cardiology Unit, Interdisciplinary Department of Medicine (DIM), \u201cAldo Moro\u201d University School of Medicine, AOUC Polyclinic of Bari, Bari, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Carella","sequence":"additional","affiliation":[{"name":"From the University Cardiology Unit, Interdisciplinary Department of Medicine (DIM), \u201cAldo Moro\u201d University School of Medicine, AOUC Polyclinic of Bari, Bari, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Basile","sequence":"additional","affiliation":[{"name":"From the University Cardiology Unit, Interdisciplinary Department of Medicine (DIM), \u201cAldo Moro\u201d University School of Medicine, AOUC Polyclinic of Bari, Bari, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Forleo","sequence":"additional","affiliation":[{"name":"From the University Cardiology Unit, Interdisciplinary Department of Medicine (DIM), \u201cAldo Moro\u201d University School of Medicine, AOUC Polyclinic of Bari, Bari, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Matteo","family":"Ciccone","sequence":"additional","affiliation":[{"name":"From the University Cardiology Unit, Interdisciplinary Department of Medicine (DIM), \u201cAldo Moro\u201d University School of Medicine, AOUC Polyclinic of Bari, Bari, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Igoren","family":"Guaricci","sequence":"additional","affiliation":[{"name":"From the University Cardiology Unit, Interdisciplinary Department of Medicine (DIM), \u201cAldo Moro\u201d University School of Medicine, AOUC Polyclinic of Bari, Bari, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,11]]},"reference":[{"key":"R1-20260605","doi-asserted-by":"crossref","first-page":"796926","DOI":"10.1155\/2012\/796926","article-title":"Cardiomyopathy classification: ongoing debate in the genomics era.","volume":"2012","author":"McCartan","year":"2012","journal-title":"Biochem Res Int"},{"key":"R2-20260605","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC).","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"R3-20260605","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1253\/circj.CJ-14-0893","article-title":"Inherited cardiomyopathies.","volume":"78","author":"Towbin","year":"2014","journal-title":"Circ J"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies.","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"key":"R5-20260605","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10741-022-10235-9","article-title":"Clinical application of CMR in cardiomyopathies: evolving concepts and techniques: a position paper of myocardial and pericardial diseases and cardiac magnetic resonance working groups of Italian Society of Cardiology.","volume":"28","author":"Merlo","year":"2023","journal-title":"Heart Fail Rev"},{"issue":"Suppl 1","key":"R6-20260605","first-page":"e36","article-title":"Acute clinical presentation of nonischemic cardiomyopathies: early detection by cardiovascular magnetic resonance.","volume":"24","author":"Todiere","year":"2023","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R7-20260605","first-page":"00346-1","article-title":"ECG\/echo indexes in the diagnostic approach to amyloid cardiomyopathy: a head-to-head comparison from the AC-TIVE study.","volume":"S0953-6205","author":"Pagura","year":"2023","journal-title":"Eur J Intern Med"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jcct.2023.04.005","article-title":"Quantification of extracellular volume with cardiac computed tomography in patients with dilated cardiomyopathy.","volume":"17","author":"Baggiano","year":"2023","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"R9-20260605","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1093\/eurjpc\/zwab127","article-title":"A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization-the first insight from the AC-TIVE study.","volume":"29","author":"Merlo","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"R10-20260605","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1017\/S0033291721001185","article-title":"What is a mental disorder? An exemplar-focused approach.","volume":"51","author":"Stein","year":"2021","journal-title":"Psychol Med"},{"key":"R11-20260605","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1017\/S1092852916000316","article-title":"Psychotic disorders in DSM-5 and ICD-11.","volume":"21","author":"Biedermann","year":"2016","journal-title":"CNS Spectr"},{"key":"R12-20260605","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.semcdb.2017.10.016","article-title":"Gene-environment interaction and psychiatric disorders: review and future directions.","volume":"77","author":"Assary","year":"2018","journal-title":"Semin Cell Dev Biol"},{"key":"R13-20260605","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ije\/dyu038","article-title":"The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013.","volume":"43","author":"Steel","year":"2014","journal-title":"Int J Epidemiol"},{"key":"R14-20260605","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11936-019-0724-5","article-title":"Psychosocial stress and cardiovascular disease.","volume":"21","author":"Dar","year":"2019","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"R15-20260605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10253890802046281","article-title":"Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models.","volume":"12","author":"Grippo","year":"2009","journal-title":"Stress"},{"key":"R16-20260605","doi-asserted-by":"crossref","first-page":"19","DOI":"10.31887\/DCNS.2007.9.1\/bbondy","article-title":"Common genetic factors for depression and cardiovascular disease.","volume":"9","author":"Bondy","year":"2007","journal-title":"Dialogues Clin Neurosci"},{"key":"R17-20260605","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.tcm.2019.05.001","article-title":"Depression and cardiovascular disease: the deep blue sea of women\u2019s heart.","volume":"30","author":"Bucciarelli","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"R18-20260605","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure.","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"R19-20260605","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7.","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"R20-20260605","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12888-020-02885-6","article-title":"The reliability and validity of PHQ-9 in patients with major depressive disorder in psychiatric hospital.","volume":"20","author":"Sun","year":"2020","journal-title":"BMC Psychiatry"},{"key":"R21-20260605","first-page":"102","article-title":"Rapid screening for generalized anxiety disorder in patients with migraine.","volume":"20","author":"Veisy","year":"2021","journal-title":"Curr J Neurol"},{"key":"R22-20260605","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/PSY.0000000000000322","article-title":"Patient health questionnaire anxiety and depression scale: initial validation in three clinical trials.","volume":"78","author":"Kroenke","year":"2016","journal-title":"Psychosom Med"},{"key":"R23-20260605","doi-asserted-by":"crossref","first-page":"e6460","DOI":"10.5867\/medwave.2016.05.6460","article-title":"Psychological disorders in adults with inherited cardiomyopathies and Takotsubo syndrome.","volume":"16","author":"Su\u00e1rez Bagnasco","year":"2016","journal-title":"Medwave"},{"key":"R24-20260605","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ijcard.2014.04.062","article-title":"The burden and trends of psychiatric co-morbidities amongst patients with cardiomyopathy.","volume":"174","author":"Teo","year":"2014","journal-title":"Int J Cardiol"},{"key":"R25-20260605","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.genhosppsych.2007.09.005","article-title":"Psychiatric disorders in hypertrophic cardiomyopathy.","volume":"30","author":"Morgan","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"key":"R26-20260605","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0022-3999(00)00140-9","article-title":"Panic disorder and idiopathic cardiomyopathy.","volume":"48","author":"Griez","year":"2000","journal-title":"J Psychosom Res"},{"key":"R27-20260605","first-page":"5691","article-title":"Factors influencing the anxiety and depression of patients with dilated cardiomyopathy.","volume":"7","author":"Guan","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"R28-20260605","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/heart.83.6.645","article-title":"Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy.","volume":"83","author":"Steptoe","year":"2000","journal-title":"Heart"},{"key":"R29-20260605","first-page":"18","article-title":"General and disease-specific psychosocial adjustment in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy with implantable cardioverter defibrillators: a large cohort study.","volume":"5","author":"James","year":"2012","journal-title":"Circulation"},{"key":"R30-20260605","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/13506129.2016.1208081","article-title":"Depression and anxiety in patients with AL amyloidosis as assessed by the SF-36 questionnaire: experience in 1226 patients.","volume":"23","author":"Shu","year":"2016","journal-title":"Amyloid"},{"key":"R31-20260605","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2190\/JKFW-3WXK-QA7N-BYLN","article-title":"Psychiatric disorders in patients with Fabry\u2019s disease.","volume":"23","author":"Grewal","year":"1993","journal-title":"Int J Psychiatry Med"},{"key":"R32-20260605","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.14336\/AD.2021.0526","article-title":"Depression and dementia in older adults: a neuropsychological review.","volume":"12","author":"Tetsuka","year":"2021","journal-title":"Aging Dis"},{"key":"R33-20260605","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jcmg.2023.03.015","article-title":"Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy in ischemic cardiomyopathy: the DERIVATE-ICM international registry.","volume":"16","author":"Pontone","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"R34-20260605","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1093\/ehjci\/jeac169","article-title":"Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy.","volume":"23","author":"Al\u2019Aref","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R35-20260605","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ahj.2004.06.031","article-title":"Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks.","volume":"149","author":"Pedersen","year":"2005","journal-title":"Am Heart J"},{"key":"R36-20260605","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/clinpract13020036","article-title":"Association of depression and anxiety with cardiac structural and functional characteristics in heart failure with reduced and mildly reduced ejection fraction.","volume":"13","author":"Szabo","year":"2023","journal-title":"Clin Pract"},{"key":"R37-20260605","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.amjmed.2022.01.053","article-title":"Psychological stress and heart disease: fact or folklore?","volume":"135","author":"Levine","year":"2022","journal-title":"Am J Med"},{"key":"R38-20260605","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.3390\/ijms21186546","article-title":"Neuroinflammation-associated alterations of the brain as potential neural biomarkers in anxiety disorders.","volume":"21","author":"Won","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R39-20260605","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tcm.2015.05.001","article-title":"Stress-induced cardiac arrhythmias: the heart-brain interaction.","volume":"26","author":"Buckley","year":"2016","journal-title":"Trends Cardiovasc Med"},{"key":"R40-20260605","doi-asserted-by":"crossref","first-page":"300060518814606","DOI":"10.1177\/0300060518814606","article-title":"Chronic stress: a crucial promoter of cell apoptosis in atherosclerosis.","volume":"48","author":"Meng","year":"2020","journal-title":"J Int Med Res"},{"key":"R41-20260605","doi-asserted-by":"crossref","first-page":"93","DOI":"10.31887\/DCNS.2004.6.1\/ccarvajal","article-title":"Poor response to treatment: beyond medication.","volume":"6","author":"Carvajal","year":"2004","journal-title":"Dialogues Clin Neurosci"},{"key":"R42-20260605","doi-asserted-by":"crossref","first-page":"05","DOI":"10.18332\/tid\/116411","article-title":"Association between persistent smoking after a diagnosis of heart failure and adverse health outcomes: a systematic review and meta-analysis.","volume":"18","author":"Son","year":"2020","journal-title":"Tob Induc Dis"},{"key":"R43-20260605","doi-asserted-by":"crossref","first-page":"736","DOI":"10.5498\/wjp.v11.i10.736","article-title":"Antipsychotics cardiotoxicity: what\u2019s known and what\u2019s next.","volume":"11","author":"Li","year":"2021","journal-title":"World J Psychiatry"},{"key":"R44-20260605","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIR.0000000000000426","article-title":"Drugs that may cause or exacerbate heart failure.","volume":"134","author":"Page","year":"2016","journal-title":"Circulation"},{"key":"R45-20260605","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1253\/circj.72.847","article-title":"Complete atrioventricular block secondary to lithium therapy.","volume":"72","author":"Shiraki","year":"2008","journal-title":"Circ J"},{"key":"R46-20260605","doi-asserted-by":"crossref","first-page":"29","DOI":"10.31887\/DCNS.2007.9.1\/jchuffman","article-title":"Neuropsychiatric consequences of cardiovascular medications.","volume":"9","author":"Huffman","year":"2007","journal-title":"Dialogues Clin Neurosci"},{"key":"R47-20260605","doi-asserted-by":"crossref","first-page":"e0181842","DOI":"10.1371\/journal.pone.0181842","article-title":"Targeted next-generation sequencing detects novel gene-phenotype associations and expands the mutational spectrum in cardiomyopathies.","volume":"12","author":"Forleo","year":"2017","journal-title":"PLoS One"},{"key":"R48-20260605","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/CIRCHEARTFAILURE.114.001105","article-title":"Danon disease: clinical features, evaluation, and management.","volume":"7","author":"D\u2019Souza","year":"2014","journal-title":"Circ Heart Fail"},{"key":"R49-20260605","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.conb.2021.01.002","article-title":"Ankyrins and neurological disease.","volume":"69","author":"Stevens","year":"2021","journal-title":"Curr Opin Neurobiol"},{"key":"R50-20260605","doi-asserted-by":"crossref","first-page":"e1673","DOI":"10.1002\/mgg3.1673","article-title":"Expanding the phenotype of CACNA1C mutation disorders.","volume":"9","author":"Gakenheimer-Smith","year":"2021","journal-title":"Mol Genet Genomic Med"},{"key":"R51-20260605","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1176\/appi.ajp-rj.2019.140504","article-title":"Association of thyrotoxicosis with mania.","volume":"14","author":"Adiba","year":"2019","journal-title":"Am J Psychiatry Residents J"},{"key":"R52-20260605","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MED.0000000000000089","article-title":"Psychiatric and cognitive manifestations of hypothyroidism.","volume":"21","author":"Samuels","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R53-20260605","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1744-859X-12-23","article-title":"Psychiatric symptoms as a clinical presentation of Cushing\u2019s syndrome.","volume":"12","author":"Tang","year":"2013","journal-title":"Ann Gen Psychiatry"},{"key":"R54-20260605","doi-asserted-by":"crossref","first-page":"e121011","DOI":"10.5812\/ijem.121011","article-title":"Psychotic disorder as the first manifestation of Addison disease: a case report.","volume":"20","author":"Momayez Sanat","year":"2022","journal-title":"Int J Endocrinol Metab"},{"key":"R55-20260605","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/PRBM.S183950","article-title":"Executive functioning and quality of life in acromegaly.","volume":"12","author":"Solomon","year":"2019","journal-title":"Psychol Res Behav Manag"},{"key":"R56-20260605","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.3390\/ijms23116224","article-title":"Neuroinflammation in vascular cognitive impairment and dementia: current evidence, advances, and prospects.","volume":"23","author":"Tian","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R57-20260605","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10741-022-10276-0","article-title":"Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunction.","volume":"28","author":"Ghio","year":"2023","journal-title":"Heart Fail Rev"},{"key":"R58-20260605","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.tcm.2017.11.005","article-title":"Current interpretation of myocardial stunning.","volume":"28","author":"Guaricci","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"R59-20260605","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2013.05.072","article-title":"Clinical characteristics and outcomes of young and very young adults with heart failure: the CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity).","volume":"62","author":"Wong","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R60-20260605","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.2009.454","article-title":"Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.","volume":"301","author":"O\u2019Connor","year":"2009","journal-title":"JAMA"},{"key":"R61-20260605","first-page":"44","article-title":"The importance of psychosocial support in youth dilated cardiomyopathy patient who underwent cardiac rehabilitation.","volume":"28","author":"Abulimiti","year":"2023","journal-title":"J Cardiol Cases"},{"key":"R62-20260605","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/eurjpc\/zwac260","article-title":"Risk of incident mental disorders in hypertrophic cardiomyopathy: a nationwide propensity-matched study.","volume":"30","author":"Park","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"R63-20260605","doi-asserted-by":"crossref","first-page":"890506","DOI":"10.3389\/fcvm.2022.890506","article-title":"Anxiety predicts poor prognosis in patients with hypertrophic cardiomyopathy.","volume":"9","author":"He","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R64-20260605","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1540-8159.2010.02770.x","article-title":"Emotional stress triggers symptoms in hypertrophic cardiomyopathy: a survey of the hypertrophic cardiomyopathy association.","volume":"33","author":"Lampert","year":"2010","journal-title":"Pacing Clin Electrophysiol"},{"key":"R65-20260605","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.amjcard.2007.06.063","article-title":"Depression, anxiety, and quality of life in patients with obstructive hypertrophic cardiomyopathy three months after alcohol septal ablation.","volume":"100","author":"Serber","year":"2007","journal-title":"Am J Cardiol"},{"key":"R66-20260605","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1161\/01.CIR.0000031733.51374.C1","article-title":"Emotional and physical precipitants of ventricular arrhythmia.","volume":"106","author":"Lampert","year":"2002","journal-title":"Circulation"},{"key":"R67-20260605","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/ha.2008.000216","article-title":"Recent advances in diagnosis and management of hypertrophic cardiomyopathy.","volume":"1","author":"Siswanto","year":"2009","journal-title":"Heart Asia"},{"key":"R68-20260605","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/GIM.0b013e3181612cc7","article-title":"Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy.","volume":"10","author":"Ingles","year":"2008","journal-title":"Genet Med"},{"key":"R69-20260605","first-page":"2","article-title":"Anxiety in patients with arrhythmogenic right ventricular cardiomyopathy and implantable cardioverter defibrillators.","volume":"5","author":"Day","year":"2012","journal-title":"Circulation"},{"key":"R70-20260605","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.3390\/jcm9123804","article-title":"Psychosocial stress hastens disease progression and sudden death in mice with arrhythmogenic cardiomyopathy.","volume":"9","author":"Agrimi","year":"2020","journal-title":"J Clin Med"},{"issue":"11, Part 2","key":"R71-20260605","first-page":"2345","article-title":"Myocardial amyloidosis: the exemplar interstitial disease.","volume":"12","author":"Fontana","year":"2019","journal-title":"JACC"},{"key":"R72-20260605","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1474515114566737","article-title":"Anxiety and depression among amyloid light-chain cardiac amyloidosis patients: the role of life satisfaction.","volume":"15","author":"Smorti","year":"2016","journal-title":"Eur J Cardiovasc Nurs"},{"key":"R73-20260605","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jad.2014.04.072","article-title":"Anxiety and depression among haematological cancer patients attending treatment centres: prevalence and predictors.","volume":"165","author":"Clinton-McHarg","year":"2014","journal-title":"J Affect Disord"},{"key":"R74-20260605","doi-asserted-by":"crossref","first-page":"1066224","DOI":"10.3389\/fpsyg.2022.1066224","article-title":"Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis.","volume":"13","author":"Smorti","year":"2022","journal-title":"Front Psychol"},{"key":"R75-20260605","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","article-title":"Cardiac involvement in Fabry disease: JACC review topic of the week.","volume":"77","author":"Pieroni","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R76-20260605","doi-asserted-by":"crossref","first-page":"829128","DOI":"10.3389\/fpsyt.2022.829128","article-title":"Neuropsychiatric symptoms and their association with sex, age, and enzyme replacement therapy in Fabry disease: a systematic review.","volume":"13","author":"Mroczek","year":"2022","journal-title":"Front Psychiatry"},{"key":"R77-20260605","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/diseases9040072","article-title":"Survey about the quality of life of Italian patients with Fabry disease.","volume":"9","author":"Polistena","year":"2021","journal-title":"Diseases (Basel)"},{"key":"R79-20260605","first-page":"100547","article-title":"Depression, sleep disturbances, pain, disability and quality of LIFE in Brazilian Fabry disease patients.","volume":"22","author":"Rosa Neto","year":"2020","journal-title":"Mol Genet Metab Rep"},{"key":"R80-20260605","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/europace\/euaa171","article-title":"Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study.","volume":"22","author":"Peretto","year":"2020","journal-title":"Europace"},{"key":"R81-20260605","doi-asserted-by":"crossref","first-page":"oeab046","DOI":"10.1093\/ehjopen\/oeab046","article-title":"Sacubitril\/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register.","volume":"2","author":"Pastore","year":"2022","journal-title":"Eur Heart J Open"},{"key":"R82-20260605","doi-asserted-by":"crossref","first-page":"111182","DOI":"10.1016\/j.jpsychores.2023.111182","article-title":"The link between cardiac status and depression and anxiety in implantable cardioverter defibrillator patients: design and first results of the PSYCHE-ICD study.","volume":"167","author":"van der Lingen","year":"2023","journal-title":"J Psychosom Res"},{"key":"R83-20260605","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jacc.2019.01.041","article-title":"Screening and management of depression in patients with cardiovascular disease: JACC state-of-the-art review.","volume":"73","author":"Jha","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R84-20260605","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.biopsych.2009.12.012","article-title":"Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis.","volume":"67","author":"Kemp","year":"2010","journal-title":"Biol Psychiatry"},{"key":"R85-20260605","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/PSY.0b013e3181b39aa1","article-title":"Association between symptoms of depression and anxiety with heart rate variability in patients with implantable cardioverter defibrillators.","volume":"71","author":"Francis","year":"2009","journal-title":"Psychosom Med"},{"key":"R86-20260605","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1002\/ehf2.13416","article-title":"Changes in quality of life, depression, general anxiety, and heart-focused anxiety after defibrillator implantation.","volume":"8","author":"Kindermann","year":"2021","journal-title":"ESC Heart Fail"},{"key":"R87-20260605","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3390\/jcm9051365","article-title":"Psychosocial impact of predictive genetic testing in hereditary heart diseases: the PREDICT study.","volume":"9","author":"Bordet","year":"2020","journal-title":"J Clin Med"},{"key":"R88-20260605","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/ejhg.2016.36","article-title":"22 years of predictive testing for Huntington\u2019s disease: the experience of the UK Huntington\u2019s Prediction Consortium.","volume":"24","author":"Baig","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"R89-20260605","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3389\/fgene.2018.00624","article-title":"A systematic review of the psychological implications of genetic testing: a comparative analysis among cardiovascular, neurodegenerative and cancer diseases.","volume":"9","author":"Oliveri","year":"2018","journal-title":"Front Genet"},{"key":"R90-20260605","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10897-017-0186-4","article-title":"Examining the psychosocial impact of genetic testing for cardiomyopathies.","volume":"27","author":"Wynn","year":"2018","journal-title":"J Genet Couns"},{"key":"R91-20260605","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12877-020-01872-6","article-title":"Is preoperative anxiety associated with postoperative delirium in older persons undergoing cardiac surgery? Secondary data analysis of a randomized controlled trial.","volume":"20","author":"Milisen","year":"2020","journal-title":"BMC Geriatr"},{"key":"R92-20260605","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/medicina57020155","article-title":"Neuropsychiatric consequences of lipophilic beta-blockers.","volume":"57","author":"Cojocariu","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"R93-20260605","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.3390\/ijms231710099","article-title":"Propranolol versus other selected drugs in the treatment of various types of anxiety or stress, with particular reference to stage fright and post-traumatic stress disorder.","volume":"23","author":"Szeleszczuk","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R94-20260605","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40264-021-01140-5","article-title":"\u03b2-Blockers and the risk of depression: a matched case-control study.","volume":"45","author":"Bornand","year":"2022","journal-title":"Drug Saf"},{"key":"R95-20260605","first-page":"125","article-title":"The association of beta-blocker use to cognitive impairment among adults with hypertension or cardiovascular diseases in the United States.","volume":"4","author":"Safarudin","year":"2020","journal-title":"Chron Pain Manage"},{"key":"R96-20260605","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/070674379103600428","article-title":"Manic symptoms associated with the use of captopril.","volume":"36","author":"Patten","year":"1991","journal-title":"Can J Psychiatry"},{"key":"R97-20260605","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1176\/ajp.150.9.1429","article-title":"Captopril-induced mania.","volume":"150","author":"Gajula","year":"1993","journal-title":"Am J Psychiatry"},{"key":"R98-20260605","doi-asserted-by":"crossref","first-page":"109","DOI":"10.31887\/DCNS.2011.13.1\/ccelano","article-title":"Depressogenic effects of medications: a review.","volume":"13","author":"Celano","year":"2011","journal-title":"Dialogues Clin Neurosci"},{"key":"R99-20260605","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ehf2.14155","article-title":"Deformation imaging by strain in chronic heart failure over sacubitril-valsartan: a multicenter echocardiographic registry.","volume":"10","author":"Mandoli","year":"2023","journal-title":"ESC Heart Fail"},{"key":"R100-20260605","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00213-011-2257-9","article-title":"Cognitive enhancement following acute losartan in normotensive young adults.","volume":"217","author":"Mechaeil","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"R101-20260605","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1399-5618.2008.00636.x","article-title":"Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms.","volume":"10","author":"Mallinger","year":"2008","journal-title":"Bipolar Disord"},{"key":"R102-20260605","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00023210-199504010-00005","article-title":"The role of calcium channel blockers in the treatment of psychiatric disorders.","volume":"4","author":"Dubovsky","year":"1995","journal-title":"CNS Drugs"},{"key":"R103-20260605","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1097\/CM9.0000000000001875","article-title":"Association between common cardiovascular drugs and depression.","volume":"134","author":"Tao","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"R104-20260605","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s13730-021-00669-9","article-title":"A case of Wernicke encephalopathy arising in the early stage after the start of hemodialysis.","volume":"11","author":"Seto","year":"2022","journal-title":"CEN Case Rep"},{"key":"R105-20260605","doi-asserted-by":"crossref","first-page":"e920016","DOI":"10.12659\/AJCR.920016","article-title":"A case of salicylate toxicity presenting with acute focal neurologic deficit in a 61-year-old woman with a history of stroke.","volume":"21","author":"Delaney","year":"2020","journal-title":"Am J Case Rep"},{"key":"R106-20260605","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1002\/gps.4767","article-title":"Aspirin and incident depressive symptoms: a longitudinal cohort study over 8 years.","volume":"33","author":"Veronese","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"key":"R107-20260605","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.tcm.2018.09.005","article-title":"Amiodarone and thyroid physiology, pathophysiology, diagnosis and management.","volume":"29","author":"Trohman","year":"2019","journal-title":"Trends Cardiovasc Med"},{"key":"R108-20260605","first-page":"260","article-title":"Hypothyroidism presenting as psychosis: myxedema madness revisited.","volume":"5","author":"Heinrich","year":"2003","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"R109-20260605","first-page":"440","article-title":"Hyperthyroidism--cause of depression and psychosis: a case report.","volume":"2","author":"Marian","year":"2009","journal-title":"J Med Life"},{"key":"R110-20260605","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1176\/ajp.144.4.506","article-title":"Toxic neuropsychiatric effects of digoxin at therapeutic serum concentrations.","volume":"144","author":"Eisendrath","year":"1987","journal-title":"Am J Psychiatry"},{"key":"R111-20260605","doi-asserted-by":"crossref","first-page":"201","DOI":"10.9740\/mhc.2016.07.201","article-title":"Drug-induced cognitive impairment: effect of cardiovascular agents.","volume":"6","author":"Marvanova","year":"2016","journal-title":"Mental Health Clin"},{"key":"R112-20260605","first-page":"1365","article-title":"Update on statin treatment in patients with neuropsychiatric disorders.","volume":"11","author":"Avan","year":"2021","journal-title":"Life (Basel)"},{"key":"R113-20260605","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","article-title":"Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism.","volume":"8","author":"Golomb","year":"2008","journal-title":"Am J Cardiovasc Drugs"},{"key":"R114-20260605","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1037\/amp0000298","article-title":"Teamwork in healthcare: key discoveries enabling safer, high-quality care.","volume":"73","author":"Rosen","year":"2018","journal-title":"Am Psychol"},{"key":"R115-20260605","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpsychores.2013.08.001","article-title":"Patient health questionnaire-9 score and adverse cardiac outcomes in patients hospitalized for acute cardiac disease.","volume":"75","author":"Beach","year":"2013","journal-title":"J Psychosom Res"},{"key":"R116-20260605","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s12529-015-9475-1","article-title":"Health status and psychological distress in patients with non-compaction cardiomyopathy: the role of burden related to symptoms and genetic vulnerability.","volume":"22","author":"Brouwers","year":"2015","journal-title":"Int J Behav Med"},{"key":"R117-20260605","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12991-022-00379-1","article-title":"Measuring patient satisfaction in an outpatient psychiatric clinic. What factors play a role?","volume":"21","author":"Romanowicz","year":"2022","journal-title":"Ann Gen Psychiatry"},{"key":"R118-20260605","doi-asserted-by":"crossref","first-page":"f288","DOI":"10.1136\/bmj.f288","article-title":"QT interval and antidepressant use: a cross sectional study of electronic health records.","volume":"346","author":"Castro","year":"2013","journal-title":"BMJ"},{"key":"R119-20260605","doi-asserted-by":"crossref","first-page":"e057085","DOI":"10.1136\/bmjopen-2021-057085","article-title":"The heart & mind trial: intervention with cognitive\u2013behavioural therapy in patients with cardiac disease and anxiety: randomised controlled trial protocol.","volume":"11","author":"Selina Kikkenborg","year":"2021","journal-title":"BMJ Open"},{"key":"R120-20260605","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40279-013-0090-5","article-title":"The effects of stress on physical activity and exercise.","volume":"44","author":"Stults-Kolehmainen","year":"2014","journal-title":"Sports Med"},{"key":"R121-20260605","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41569-021-00611-7","article-title":"The role of cardiac rehabilitation in improving cardiovascular outcomes.","volume":"19","author":"Taylor","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"R122-20260605","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/eurjcn\/zvac001","article-title":"A systematic review, meta-analysis, and meta-regression of patient education for secondary prevention in patients with coronary heart disease: impact on psychological outcomes.","volume":"21","author":"Shi","year":"2022","journal-title":"Eur J Cardiovasc Nurs"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:00:49Z","timestamp":1780671649000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,11]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000693","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,11]]}}}